Care for horses & livestock/farm animals
Care for cats, dogs & other companion animals
Throughout the year, Penn Vet hosts seminars, conferences, symposiums, and speaker series, which serve as forums for academics to share the latest research approaches breakthroughs in a wide array of subjects.
Read the Penn Vet Research Newsletter to get the latest news about our faculty researchers, programs, projects, grants, and publications... Better yet, sign up to receive the latest Research Newsletter by email.
Creating an effective gene therapy for inherited diseases requires three key steps. First, scientists must identify and characterize the disease. Second, they must find the gene responsible. And finally, they must find a way to correct the impairment.
[PHILADELPHIA, September 12, 2019] - A new core facility, the first on the east coast to exclusively focus on the isolation and characterization of extracellular vesicles, has opened at the University of Pennsylvania’s School of Veterinary Medicine (Penn Vet). The Extracellular Vesicle Core Facility at Penn Vet supports investigators with the necessary scientific and technical capabilities to define, standardize and monitor research in pathological and physiological conditions.
Nearly two decades ago, a gene therapy restored vision to Lancelot, a Briard dog who was born with a blinding disease. This ushered in a period of hope and progress for the field of gene therapy aimed at curing blindness, which culminated in the 2017 approval of a gene therapy that improved vision in people with Leber congenital amaurosis (LCA), a rare, inherited form of blindness closely related to the condition seen in Lancelot. It represents the first FDA-approved gene therapy for an inherited genetic disease.
Much remains mysterious about the factors influencing human inflammatory bowel disease (IBD), but one aspect that has emerged as a key contributor is the gut microbiome, the collection of microorganisms dwelling in the intestines.